Modonutti D, Majdalany SE, Butaney M, Davis MJ, et al. Conditional survival does not improve over time in metastatic castration-resistant prostate cancer patients undergoing docetaxel. Prostate 2023 Jun 8. doi: 10.1002/pros.24583.
PMID: 37290911